[1,2,4]thiadiazine 1,1-dioxide compounds
US8097613B2 · kind B2 · utility
1Cited by
3References
28Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 9, 2009 |
| Grant date | Jan 17, 2012 |
| Priority date | — |
| Expiry date | Feb 16, 2030 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D417/04
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The invention is directed to [1,2,4]thiadiazine 1,1-dioxide compounds of formula Iwherein A isB isand pharmaceutical compositions containing such compounds that are useful in treating infections by hepatitis C virus.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.